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Disparities in Health in the United States: An Overview of the
Social Determinants of Health for Otolaryngologists
Regan W. Bergmark, MD ; Ahmad R. Sedaghat, MD, PhD
Objectives: Social determinants of health include social and demographic factors such as poverty, education status, race
and ethnicity, gender, insurance status, and other factors that influence (1) development of illness, (2) ability to obtain and uti-
lize healthcare, and (3) health and healthcare outcomes. In otolaryngology, as in other subspecialty surgical fields, we are con-
stantly confronted by patients’ social and demographic circumstances including poverty, language barriers, and lack of health
insurance and yet there is limited research on how these factors impact health equity in our field, or how attention to these
patient characteristics may improve health equity. This review provides the reader with a framework to understand the social
determinants of health including how socioeconomic status, insurance status, race, gender, and other factors impact health.
Data Sources and Review Methods: Foundational papers on the social determinants of health are reviewed, as well as
otolaryngology publications focused on health and healthcare disparities.
Results: The social determinants of health have a major impact on patient health as well as healthcare utilization, but
there is a relative lack of data on these factors and how they can be addressed within otolaryngology. Incorporating tools to
measure social and demographic characteristics and actually report on these measures is a first simple step to increase the
data on the social determinants of health as they pertain to otolaryngology.
Conclusion: More research is needed on the social determinants of health, and how they impact otolaryngic disease.
Medicare’s Accountable Care Organization models will increasingly change the way in which physicians are reimbursed, mak-
ing the social determinants of health central not only to our moral conscience but also the bottom line.
Key Words: Healthcare disparities, healthcare delivery, insurance, socioeconomic factors, primary care, uninsured,
Medicaid.
Level of Evidence: 4
INTRODUCTION
Social determinants of health are defined as the
demographic and social factors that underlie development
of illness, access to medical care, adherence to treatment
plans, and outcomes.1,2 Mortality is more closely tied to
the social determinants of health than to medical care
per se. Patients who are poor or part of an ethnic or
racial minority are more likely to have a smoking history
and less likely to have access to medical care. Technically
perfect surgery can have poor results if underlying social
determinants of health are not considered–a waste for
both patient and surgeon. As in clinical vignette 1 (Fig. 1)
below, the development, timely diagnosis and treatment
of oropharyngeal squamous cell carcinoma (OPSCC) is
intimately tied to social determinants of health such as
human papillomavirus (HPV) vaccination status, smoking
history, poverty, health literacy, and health insurance sta-
tus. Other factors such as race also impact whether
patients present with early or late stage OPSCC. The
ability to intervene and prevent or successfully treat
OPSCC therefore hinges partly on understanding at-risk
groups as well as racial, gender, and socioeconomic dis-
parities in head and neck cancer prevalence.3
While not a common focus in otolaryngology, social
determinants of health have been heavily researched in
other medical fields with a focus on restoring health
equity and good outcomes for patients of all backgrounds.
Health equity is founded in ethics and human rights
principles.4–6 Structural violence, a term popularized by
the renowned physician and medical anthropologist Dr.
Paul Farmer, refers to “social arrangements that put indi-
viduals and populations in harm’s way.”7 Structural vio-
lence for otolaryngology patients may include things such
as lack of health insurance or healthcare access, poor
health literacy, poverty, exposure to violence or trauma,
and discrimination leading to poor health or healthcare
outcomes. Farmer advocates for interventions that elimi-
nate the barriers disadvantaged patients have to seeking
care, and has used his approach to dramatically improve
morbidity and mortality across disease processes in multi-
ple countries including Haiti and the United States.
Despite their obvious importance in prognosis and
clinical care, measures of social determinants of health are
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not frequently a focus of research or clinical investigation
in otolaryngology and warrant further development and
utilization. For some disease processes such as chronic rhi-
nosinusitis, national prevalence studies reveal an under-
representation of poorer patients and patients from ethnic
minorities; are these patients not getting sick or–perhaps
more likely–simply not making it in to subspecialty
centers, never being diagnosed, and never being treated?
Public reporting of outcomes by race and socioeconomic
status (SES) has been advocated as an approach to exam-
ining and reducing healthcare inequity.2 Delineating the
reasons for health inequity on a societal level allows for
effective and meaningful intervention.8
Aside from the moral ramifications, social determi-
nants of health will increasingly matter for reimbursements
from Medicare and in Accountable Care Organization (ACO)
models, for physicians in all fields, as well as in bundled pay-
ment models.9,10 In ACO models, a patient’s overall health
outcome as well as cost of care will affect reimbursement
and will define whether a provider or institution is consid-
ered high or low performing. Assuming these are not fully
eliminated in the rapidly changing health policy arena, ini-
tially there will be incentives to perform highly. Eventually
it is expected that patients will be preferentially shunted to
high value providers. While many ACO outcomes measures
currently focus on chronic medical diseases or common med-
ical conditions, there will likely be increasing emphasis on
surgical outcomes and management.11 Factors impacting
patient outcomes, such as chronic disease management,
smoking status and preventative health measures that are
affected by social determinants of health may directly
impact reimbursement. They therefore will need to be con-
sidered part of the routine care of patients, even for subspe-
cialty surgical practices.
The Divide: Health Expenditures and Health
Outcomes
In the United States, health outcomes have not
matched healthcare expenditures because very little is
invested in public health measures to address the social
determinants of health.12 Contrary to what many in the
United States may think, Americans do not have the
best health status worldwide. In fact, the United States
was not in the top 30 countries for longest life expec-
tancy.13 Among wealthy countries, life expectancy is not
correlated with healthcare expenditures as a percent of
Gross Domestic Product (GDP); likewise, within the
United States, life expectancy is not correlated with
health expenditures in state to state comparisons.12
Policy makers often seem perplexed that there is a
chasm between healthcare/medical expenditures and
health outcomes such as life expectancy and mortality
rates. However, in the United States, healthcare expen-
ditures are heavily weighted toward medical care and
not toward public health. Medical care in this country
has mostly been reactive rather than proactive–high
costs are paid when patients have a problem but not so
for prevention. For example, we see dramatic efforts and
billions of dollars spent to treat cancer caused by smok-
ing while funding and energy spent for anti-smoking
campaigns have somewhat stalled. For the patient with
oropharyngeal cancer described in clinical vignette 1
(Fig. 1), the opportunity for prevention with HPV vacci-
nation was missed; early detection with the possibility of
simpler (and less costly) treatment was thwarted by lack
of insurance and healthcare access, and ultimately the
patient presented with late disease requiring a higher-
cost and more morbid treatment.
Social determinants of health
Social determinants of health encompass the socio-
economic and demographic factors that influence how
and why patients get sick, healthcare utilization, and
outcomes.1 By definition, these elements are broad, and
here we seek to summarize some of the foundational
research on specific categories of social determinants of
health. Social determinants of health have garnered
more attention in the past 15 years through multiple ini-
tiatives globally including the United States govern-
ment’s Healthy People initiatives,1 the World Health
Organization’s Commission on Social Determinants of
Health in 2005 and attention by the Kaiser Family
Foundation.14 Healthy People 2020 defined the social
determinants of health in broad categories as “Economic
Stability, Education, Health and Health Care, Neighbor-
hood and Built Environment, and Social and Community
Context.”15 Across the world, behavioral, environmental,
Fig. 1. Clinical vignette 1.
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occupational and metabolic (ie, dietary, physical activity)
risk factors explain more than half of mortality.16
Separate consideration of each social determinant
of health and how they interact is critical to identify at-
risk otolaryngology patients, as well as areas of potential
intervention and improvement at the patient or policy
level. For example, for the patient in clinical vignette 1
(Fig. 1), the timing of and advanced stage at presenta-
tion, and the ultimate clinical outcome could have been
impacted by policies targeting vaccination and primary
care access, insurance coverage, or other factors. In this
section, we will focus on three major social determinants
of health: (1) SES, (2) insurance status and healthcare
access, and (3) race and ethnicity. Other determinants of
health, such as gender and language–each of which
deserves its own review–are summarized briefly.
Socioeconomic Status
Income, economic stability, and education status pro-
foundly affect patients’ health and well-being, and their
ability to access and utilize medical care effectively, as
illustrated by clinical vignette 2 (Fig. 2). Patients of low
SES are more likely to suffer from chronic diseases “often
as a result of social disadvantages and vulnerability.”17
An abundance of research from the 1960s to the present
day has found that wealthier and more educated people
live longer.18–20 In describing Aaron Antonovsky’s seminal
work on SES and life expectancy,20 the World Health
Organization stated that the, “inescapable conclusion was
that social class influenced a person’s chance of staying
alive.”8,20 In the Whitehall Studies of the British Civil Ser-
vice, for example, lower-ranking officers were more likely
to have multiple risk factors for disease–they were more
likely to be obese, have hypertension, be sedentary, and
smoke; they had higher rates of cardiovascular mortality
even when these factors were controlled for.18,19 Although
not specifically included in their manuscripts, it is likely
they had higher rates of head and neck cancer than their
higher-ranking peers for all of these reasons. While lower
SES is correlated with mortality and morbidity, public
health interventions aimed at an entire population also
consistently benefit the wealthy before they reached the
poor.21
What mediates the association between lower SES
and higher mortality? Individuals of low SES are more
likely to suffer from illness because they are more likely
to be exposed to disease risk factors17 and less likely to
obtain healthcare, as illustrated by clinical vignette 2
(Fig. 2). Disease risk factors are associated with urban
poor areas, and poor access to healthy food and outdoor
space. Individuals of low SES are less likely to have
good health literacy. Patients who do not have economic
security are less likely to be able to negotiate for time
away from work for medical appointments, or to be able
to sacrifice paid hours of work to take care of their
health. Low SES patients are also less likely to be able
to access and utilize healthcare, independent of insur-
ance status, for example by influencing their ability to
pay co-pays for physician visits or medications. For the
patient in clinical vignette 2 (Fig. 2), these barriers
resulted in more frequent and severe sinus and pulmo-
nary infections and more frequent hospitalizations–ulti-
mately, a faster progression of her disease.
Insurance Status and Healthcare Access
The health insurance environment is rapidly chang-
ing, and patients who require regular otolaryngic care
and surveillance for conditions such as chronic otitis
media, hearing loss, chronic rhinosinusitis, recurrent
respiratory papillomatosis, sleep apnea, head and neck
malignancy may be facing loss of or major changes in
their insurance status in the near future. Insurance cov-
erage significantly impacts healthcare utilization and
outcomes independent of confounding factors such as
SES.22 Although the number of uninsured has dropped
with the Affordable Care Act, there were still 36 million
uninsured people (accounting for 11.5% of the popula-
tion) in the United States in 2014, with 51.6 million
uninsured at some point in the prior year.23 Nearly 6
million of the 170 million individuals who do have insur-
ance were covered in 2014 under “private plans through
the Health Insurance Marketplace or state based
exchanges” that were implemented as a part of the
Affordable Care Act.23 By 2015 the national percentage
of uninsured patients dropped to 9%.24 However, insur-
ance coverage levels do vary significantly by state due to
differences in Medicaid enrollment and policy structure,
state poverty levels, and other factors.24–26
Many studies have shown that patients with Medic-
aid and the uninsured have disproportionately worse
negative health outcomes than patients with private
insurance or Medicare. This disparity represents a major
healthcare problem impacting more than one in four
Americans.24 In otolaryngology there is poor understand-
ing of how insurance status impacts referral status,
treatment patterns, and outcomes of otolaryngic dis-
eases. However, population-level findings describing the
impact of insurance status on healthcare are broadly
applicable and likely influence sub-specialty care as
much as, perhaps more so, than in the realm of general
medicine.
The uninsured are more likely to be unable to
access medical care and to have adverse healthcare out-
comes than privately insured patients.22 These individu-
als are less likely than the privately insured to have
seen a doctor in the past year and to have received pre-
ventative health services such as a flu vaccine.26 This
Fig. 2. Clinical vignette 2.
Laryngoscope Investigative Otolaryngology 2: August 2017 Bergmark and Sedaghat: Social Determinants of Health in Surgery
189
disparity in healthcare access extends to Medicaid
patients as well.27 Studies have shown that uninsured
patients or those with Medicaid have more difficulty
finding a medical office that will accept them,28,29 expe-
rience longer wait times for appointments, and are less
likely to have a primary care physician with extended
daytime or weekend hours when compared to the pri-
vately insured. A recent study in which more than
12,000 calls were made to primary care physician offices
found that 85% of privately-insured patients were able
to make an appointment versus 58% of Medicaid
patients and only 15% of the uninsured if the cost paid
at the time of the visit was restricted to $75 or less.30
While a similar study has not yet been done to our
knowledge in otolaryngology, it is likely that the trends
remain the same.
It is not surprising then that individuals with Medic-
aid or the uninsured may present at a later stage in any
disease process. This effect has been reported for a num-
ber of otolaryngic conditions, for example, Medicaid or
uninsured patients presenting with more advanced med-
ullary thyroid cancer at the time of diagnosis.25 In head
and neck cancer patients, Medicaid insurance is associ-
ated with higher T and N classifications at time of diagno-
sis, longer time from diagnosis to initiation of treatment,
lower rates of locoregional control, and decreased overall
survival compared to private insurance.31
One downstream effect of poor access to primary
care by those with Medicaid and the uninsured is that
these patients, out of necessity, consequently seek care
in an emergency department (ED). Given the excessive
cost and inefficiency of ED utilization versus primary
care visits, as well as an underlying etiology of ED visits
attributed to poor primary care access, ED utilization
has garnered intense interest in discussions of health
policy. Patients with Medicaid or no insurance make up
a disproportionately large percentage of ED visitors, for
a variety of reasons.30 Only 29% of ED pediatric and
adult patients had private insurance across all ages in
2012,32 even though 63.9% of Americans had private
insurance that year.33 The remainder of ED patients
had coverage through Medicaid or the State Children’s
Health Insurance Program (SCHIP) (25%), Medicare
(18%) or were uninsured (14%), with the other patients
classified as “other.”32
We have studied uncomplicated acute rhinosinusitis
(ARS), a common otolaryngic disease that results in over
30 million physician visits per year, as a model disease
for understanding healthcare utilization according to
insurance status. In our studies, we found that Medicaid
(OR5 10.82, P<.001) and self-pay status (OR59.14,
P<.001) are strongly associated with presentation to an
ED for uncomplicated ARS, independent of other demo-
graphic or socioeconomic factors.34 When investigating
why that may be the case, we found an association
between Medicaid or no insurance with overnight ED
presentation, suggesting lack of access to after-hours pri-
mary care.35 Lack of evening office hours is a common
reason for ED presentation.36 We also examined whether
the quality of primary care received by Medicaid
patients was a driver of their disparately more frequent
ED use. However, we did not find any deficits in quality-
of-care indicators such as time spent with a physician or
likelihood of seeing one’s own physician for patients with
Medicaid in comparison to privately insured patients.37
Our findings suggested that poor access may have a
greater impact on ED use for ARS by Medicaid, rather
than the quality of care they receive at PCP offices.
Looking at more than 37 million PCP and ED visits for
uncomplicated ARS, we also found no differences in anti-
biotic prescribing patterns between the outpatient PCP
and ED settings, and likewise found no differences in
prescribing patterns by insurance status, for pediatric
and adult patients.38 These findings suggested that
patients’ expectation for a specific treatment likely does
not drive disparate ED utilization either for ARS. Inter-
estingly, we did find that amongst ED visits for ARS,
uninsured patients reported higher pain levels compared
to the privately insured while Medicaid patients did not
differ symptomatically from the privately insured.39 Thus
in our study of uncomplicated ARS, we find insurance-
specific healthcare disparities that are comparable with
nationwide results but we also identify nuances, such as
lack of access for Medicaid patients and greater symptom
(ie, pain) severity for the uninsured, that drive ED presen-
tation. These factors must be considered, preferably on a
disease-by-disease basis, when designing interventions or
health policy. Thus, there is a great need for further
research, even within otolaryngology, to determine the
reasons for the associations of health insurance with
healthcare utilization and outcomes.
Race and Ethnicity
Race, ethnicity, and racism are often not addressed
or discussed in otolaryngology except as variables in
studies, but research in other fields and ours shows that
racial and ethnic minorities have more health risk fac-
tors and are more likely to suffer delays in treatment or
poor outcomes. In addition to traditional barriers to care
like insurance, racial and ethnic minorities are often dis-
proportionately burdened by other risk factors for dispa-
rate healthcare as well. For example, it has been shown
that there are fewer healthcare providers in minority zip
codes, potentially leading to more difficulty obtaining
routine screening and early detection services.40 Lan-
guage and cultural barriers may also limit the quality of
care for patients in minority racial and ethnic groups or
who are not native English speakers.
The Institute of Medicine’s sweeping report on
racial and ethnic disparities in 2003 opened by saying,
“racial and ethnic minorities tend to receive a lower
quality of healthcare than non-minorities, even when
access-related factors, such as patients’ insurance status
and income, are controlled.”41 Racial and ethnic minori-
ties also are significantly underrepresented as physi-
cians in surgical subspecialties, which means not only
patient care but also decision making at a leadership
level within surgical subspecialty fields does not ade-
quately represent the U.S. population.
Multiple major otolaryngic diseases disparately
impact specific racial or ethnic minority groups due to
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risk factors, access to care and quality of care. For exam-
ple, American Indians with head and neck cancer have
been shown to have worse survival compared to White
patients and this finding is associated primarily with
socioeconomic and demographic risk factors such as alco-
hol abuse history, living far from a hospital, lack of pri-
vate insurance, and late-stage presentation.42 In
contrast, multiple traditionally recognized factors for
such disparity in survival, such as HPV status, tumor
site and grade, and time to treatments were not signifi-
cantly different between groups.43 In a recent influential
study, Dr. Sunshine Dwojak and her colleagues demon-
strated the success of easily implemented community-
based head and neck cancer screening programs for the
American Indian population, with a high positive screen-
ing rate of 8%.44
African Americans also have a higher incidence of
head and neck cancer in addition to lower 5-year sur-
vival rates compared to White patients.45 This disparity
has been attributed to demographic factors including
insurance status, health education, and “a sense of mis-
trust that is seen in the African-American population.”45
Independent of other factors, African American patients
also have a higher likelihood of having Medicaid or no
insurance, and less access to an academic medical cen-
ter. African Americans, who as a population are dispro-
portionately more economically disadvantaged, have also
been shown to have financial barriers to head and neck
cancer screening.46 Racial minority zip codes have been
associated with lower prevalence of physician providers
and higher prevalence of head and neck cancer that
White-predominant zip codes.40 For patient who are able
to access care, adherence to evidence-based guidelines
may still be unequal. For example, one study showed
that African Americans had a lower likelihood of receiving
treatment that adhered to national guidelines for medul-
lary thyroid cancer, corresponding to decreased survival
rates.47 However, equity is achievable. In a study of laryn-
geal cancer patients in the Veterans Affairs Healthcare
System, African American patients presented at the same
stage and received treatment that equally adhered to
guidelines compared to White patients.48 African Ameri-
can patients correspondingly had equal survival rates as
White patients.48
With personalized medicine on the horizon, it is
also important to realize that racial disparities may
extend to the realm of molecular medicine as well.
Racial differences in the prevalence of specific head and
neck cancer mutations, for example, have been found.49
As our field’s understanding of cancer genetics grows,
the importance of including racial and ethnic minorities
in research efforts becomes even more critical–ensuring
that the genetic diversity of the highest risk groups is
included in major genetic studies and clinical trials.
Other factors
Multiple other factors can be included in the social
determinants of health, including gender, sexual identity
and orientation, language and religion, nationality, immi-
gration status, legal status, exposure to violence, housing
security, and many other aspects of a patient’s social
environment.
Gender is an important determinant of risk factors
for multiple diseases. The risk factors for head and neck
squamous cell carcinomas, such as lack of HPV vaccina-
tion, high risk sexual behavior, and smoking all differ by
gender.50 Higher HPV rates are thought to play a dispro-
portionate role in rising OPC rates in men, while rising
smoking rates in women are central to rising cancer
rates.50 HPV conversion has been found to differ by gen-
der and also impacts HPV positivity and thus oropha-
ryngeal cancer risk. Many cancers show increased
survival for women, but the reasons for this–such as ear-
lier presentation, hormonal or genetic influences, differ-
ences in environmental exposure or other factors–likely
vary by cancer are not well understood.51 Contributing
to our gap in knowledge, women are greatly under-
represented as subjects in biomedical research.52 In one
study, women made up only 38.8% of trial participants
in an analysis of 661 cancer trials for non-gender-
specific cancers.52
A patient’s social support system including family,
friends, and religious community may impact the ability
of a patient to seek and obtain medical care. Social net-
works, Internet and computer access, and the ability to
connect with other patients who have a similar disease
or to read about one’s illness may impact where patients
obtain medical care, their adherence, and psychological
wellbeing. These factors have been shown to be impor-
tant in patients with chronic diseases, such as cystic
fibrosis for example.53 However, little is known about
the impact of patients’ social support systems on care,
treatment and outcomes for otolaryngic diseases.
In addition to the social determinants of health, the
physical determinants of health such as geography and
physical environment are also critical. Physical environ-
ment may determine allergen exposure, air quality, sun
exposure, ability to exercise, and other aspects of their
life that will determine propensity for illness. Children
in poor urban areas, for example, are more likely than
children in wealthy areas to have severe and uncon-
trolled asthma, often associated with exposure and
allergy to cockroaches, rats and mice.54–56 Patients in
poor urban areas may also have more severe or poorly
controlled chronic rhinosinusitis, but the studies simply
have not been done to investigate that.
Metrics for Social Determinants of Health
Challenges in measurement of disparities in health
and healthcare outcomes start with a lack of information
about the groups or socioeconomic circumstances in
question. Healthy People 2020 described three major
challenges for measuring health equity including, (1)
“inadequate numbers of certain highly disadvantaged
groups. . .to obtain reliable estimates”–eg, American Indi-
ans, (2) lack of any data for some minority groups–eg,
transgendered patients, (3) inadequate socioeconomic or
demographic information to clearly or correctly elucidate
disparities in health.57 Moreover, many large epidemio-
logic databases used to elucidate health disparities,
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including those provided by the Centers for Disease Con-
trol or the Agency for Healthcare Research and Quality,
contain limited patient-specific socioeconomic informa-
tion, with zip code or other characteristics substituted as
proxy measures.58
Outcomes measures are rapidly evolving. Mobile
applications may make it easier for physicians and
patients to assess and track overall health status and
associated risk factors.59,60 It may also be useful to find
ways of utilizing existing sociodemographic or de-
identified cloud-based data on patient behavior to identify
high risk patients. For example patients who do not pay
their credit card bills may be at higher risk for poor adher-
ence to medication recommendations. Ideally research on
social determinants of health, regardless of the tools or
metrics used, will be actionable research–research that
actually leads to changes in health and healthcare
utilization.
CONCLUSION
In his discussion of structural violence, Dr. Paul
Farmer asks, “Does our clinical practice acknowledge
what we already know—namely, that social and environ-
mental forces will limit the effectiveness of our
treatments?”7 We as sub-specialists must actively seek
to recognize and help address the obstacles facing our
patients. It is wasteful to our patients, to surgeons and
to the healthcare system to perform technically out-
standing surgery that results in suboptimal outcomes
due to other ameliorable factors. In an environment of
rapidly evolving health policy, we need to steer rancor-
ous policy debates toward scientific evidence about what
types of interventions are effective and worthwhile.
As we have highlighted in this review article, there
continue to be many gaps in our knowledge. The otolar-
yngology literature has generally not focused on the
social determinants of health or interventions targeted
at these underlying risk factors for poor patient out-
comes. Attention and funding is needed to develop better
and more comprehensive outcomes measures, and to
determine effective strategies to improve outcomes for
at-risk patient groups.
We, as otolaryngologists, are in a unique position
amongst subspecialists because we care for a number of
common diseases, and therefore can take a leadership
role in identifying and rectifying disparities. The condi-
tions we treat affect individuals across SES and racial
boundaries. As our work and that of others has shown,
disparities exist within our patient populations. From
rhinosinusitis to hearing loss to sleep apnea to cancer,
the conditions that we manage impact millions of indi-
viduals and lead to billions of dollars of healthcare
spending every year. As such, improving healthcare dis-
parities among our patients will not only benefit millions
of individuals but may also have the added benefit of
saving billions of healthcare dollars.
Research and clinical outcomes reports in otolaryn-
gology, where possible, should include and report on var-
iables such as race, gender, socioeconomic status, and
insurance status. More focus should be placed on
interventions to improve outcomes for otolaryngic dis-
ease for marginalized groups, including targeted studies
of groups with poor outcomes, and funding for such
research. Advocacy efforts should be made to ensure pol-
icies that improve healthcare access and insurance cov-
erage for our patients. Individual otolaryngology
practices need to think about factors such as office wait
times and availability for patients with different back-
grounds and insurance statuses.
Social problems like poverty, racism and sexism are
complex, enormous, and palpably uncomfortable and
therefore often deemed unchangeable. That fatalistic
approach, however, is frequently and unfortunately used
as a justification to ignore them. Social disparities –
unlike mortality itself – actually could be reduced or
eliminated. The social determinants of health underlie
which people become sick, how they obtain medical care
and impact healthcare outcomes. Although the bottom
line as impacted by new reimbursement models will be a
major reason to focus on these underlying causes of ill-
ness and treatment failure, ultimately the moral burden
is sufficient to take notice.
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